Ginsenoside Rg1 protects mouse liver against ischemia–reperfusion injury through anti-inflammatory and anti-apoptosis properties

Tianzhu Tao(Air Force General Hospital PLA), Xiaoming Deng(Second Military Medical University), Baoji Hu(Second Military Medical University), Qun Xie(Second Military Medical University), Yun Zou(Nanjing University of Science and Technology), Wenjing Yi(Second Military Medical University), Feng Chen(Nanjing Medical University), Jinbao Li(Qilu University of Technology), Lulong Bo
Journal of Surgical Research
March 26, 2014
10.1016/j.jss.2014.03.067
Cited by 74

Related Papers

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
|Cell|2018|448
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
|Critical Care|2010|307
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
|Critical Care|2011|254